ストックスクリーナーアプリを入手
15.59
4.24%
-0.69
アフターアワーズ：
15.70
0.11
+0.71%
前日終値:
$16.28
開ける：
$16.13
24時間の取引高:
2.30M
Relative Volume:
0.91
時価総額：
$3.71B
収益：
$488.56M
当期純損益:
$209.45M
株価収益率:
18.31
EPS:
0.8515
ネットキャッシュフロー:
$40.61M
1週間 パフォーマンス:
-2.20%
1か月 パフォーマンス:
-13.05%
6か月 パフォーマンス:
-6.98%
1年 パフォーマンス:
-1.58%
1日の値動き範囲:
$15.55
$16.14
1週間の範囲:
$15.55
$16.65
52週間の値動き範囲:
$13.76
$25.67
Adma Biologics Inc Stock (ADMA) Company Profile
Compare ADMA vs VRTX, REGN, ARGX, ALNY, ONC
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ADMA
Adma Biologics Inc
|
15.59 | 3.87B | 488.56M | 209.45M | 40.61M | 0.8515 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.02 | 117.03B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
783.65 | 82.35B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.54 | 51.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
308.48 | 42.58B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
346.42 | 38.87B | 4.98B | 69.60M | 525.67M | 0.5198 |
Adma Biologics Inc Stock (ADMA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-07-19 | 再開されました | Raymond James | Strong Buy |
| 2022-10-13 | 開始されました | Mizuho | Buy |
| 2021-11-11 | アップグレード | Raymond James | Outperform → Strong Buy |
| 2021-11-09 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-04 | 開始されました | Jefferies | Buy |
| 2019-04-15 | 繰り返されました | H.C. Wainwright | Buy |
| 2019-02-07 | 再開されました | H.C. Wainwright | Buy |
| 2017-12-11 | 繰り返されました | Maxim Group | Buy |
| 2017-11-14 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2017-01-23 | アップグレード | Maxim Group | Hold → Buy |
| 2016-08-01 | ダウングレード | Maxim Group | Buy → Hold |
| 2016-07-25 | 繰り返されました | Maxim Group | Buy |
| 2015-05-13 | 繰り返されました | Maxim Group | Buy |
| 2014-12-08 | 開始されました | Oppenheimer | Outperform |
| 2014-12-01 | 繰り返されました | Maxim Group | Buy |
すべてを表示
Adma Biologics Inc (ADMA) 最新ニュース
New York State Common Retirement Fund Decreases Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Principal Financial Group Inc. Cuts Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
Renaissance Group LLC Has $7.57 Million Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
(ADMA) Risk Channels and Responsive Allocation - Stock Traders Daily
Assessing ADMA Biologics (ADMA) Valuation After Growing Analyst Optimism On Earnings And Plasma Therapy Pipeline - Yahoo Finance
Homestead Advisers Corp Has $2.91 Million Position in ADMA Biologics Inc $ADMA - MarketBeat
Is ADMA Biologics (ADMA) Pricing Reflect A Potential Gap To DCF And P/E Estimates - Yahoo Finance
ADMA Biologics (NASDAQ:ADMA) Seems To Use Debt Rather Sparingly - 富途牛牛
Adma Biologics (ADMA) Exceeds Market Returns: Some Facts to Consider - Yahoo Finance
Federated Hermes Inc. Reduces Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc (ADMA) Stock Analysis: Unpacking A 48% Potential Upside - DirectorsTalk Interviews
Universal Beteiligungs und Servicegesellschaft mbH Cuts Stock Holdings in ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Inc $ADMA Shares Bought by Thrivent Financial for Lutherans - MarketBeat
Is it worth investing in Adma Biologics (ADMA) based on Wall Street's bullish views? - MSN
Aug Movers: Does Assured Guaranty Ltd have strong EBITDA marginsJuly 2025 Gainers & Reliable Price Action Trade Plans - baoquankhu1.vn
Returns Recap: Is Celularity Inc Equity Warrant forming higher highs and higher lowsWeekly Market Outlook & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
ADMA Biologics Inc $ADMA Shares Sold by Lisanti Capital Growth LLC - MarketBeat
Is It Worth Investing in Adma Biologics (ADMA) Based on Wall Street's Bullish Views? - Finviz
A Look At ADMA Biologics (ADMA) Valuation After Strong Analyst Support And Growing Interest In Its Therapies - Sahm
Insider Buy: Whats the beta of ADMA Biologics Inc stockDividend Hike & Low Risk Entry Point Guides - baoquankhu1.vn
Kornitzer Capital Management Inc. KS Acquires 312,115 Shares of ADMA Biologics Inc $ADMA - MarketBeat
ADMA Biologics Enters Oversold Territory (ADMA) - Nasdaq
Adma Biologics (ADMA) outpaces stock market gains: What you should know - MSN
ADMA Biologics Inc (ADMA) Stock Analysis: Unlocking A 53% Upside Potential - DirectorsTalk Interviews
Adma Biologics (ADMA) Outpaces Stock Market Gains: What You Should Know - Nasdaq
(ADMA) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Dow Update: Is ADMA Biologics Inc stock forming a cup and handleEarnings Recap Report & Weekly Return Optimization Alerts - baoquankhu1.vn
ADMA Gains 13.8% in Three Months: More Upside Potential for 2026? - Finviz
ADMA Biologics (ADMA) Is Down 5.0% After Expanding Multi-Year Revenue Guidance TargetsHas The Bull Case Changed? - Sahm
High Growth US Tech Stocks To Watch In January 2026 - Yahoo Finance
Adma Biologics (ADMA) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Campbell & CO Investment Adviser LLC Purchases Shares of 64,535 ADMA Biologics Inc $ADMA - MarketBeat
What are ADMA Biologics Inc.’s growth leversJuly 2025 Trends & Low Drawdown Investment Ideas - bollywoodhelpline.com
Can ADMA Biologics Inc. stock sustain free cash flow growthLayoff News & Community Consensus Trade Alerts - bollywoodhelpline.com
Will ADMA Biologics Inc outperform small cap indexesJuly 2025 Opening Moves & Daily Volume Surge Trade Alerts - baoquankhu1.vn
Retail Trends: Should I add ADMA Biologics Inc stock to my portfolio2025 Price Action Summary & Safe Capital Investment Plans - baoquankhu1.vn
ADMA Biologics reports preliminary 2025 results, ups 2026 outlook - MSN
Liquidity Mapping Around (ADMA) Price Events - Stock Traders Daily
ADMA Biologics, Inc. (ADMA): A Bull Case Theory - Finviz
Is Adma Biologics (ADMA) a buy as Wall Street analysts look optimistic? - MSN
ADMA Biologics: Business Update And My Price Target (NASDAQ:ADMA) - Seeking Alpha
Adma Biologics (ADMA) Sees a More Significant Dip Than Broader Market: Some Facts to Know - sharewise.com
Is Adma Biologics (ADMA) a Buy as Wall Street Analysts Look Optimistic? - sharewise.com
Breakout Zone: Whats the beta of ADMA Biologics Inc stock2025 Key Lessons & Safe Entry Momentum Stock Tips - baoquankhu1.vn
ADMA’s Upgraded Multi‑Year Revenue Targets Might Change The Case For Investing In ADMA Biologics (ADMA) - Sahm
ADMA Biologics Reports Preliminary 2025 Results, Ups 2026 Outlook - sharewise.com
How ADMA’s Multi‑Year Revenue Targets And Margin Push At ADMA Biologics (ADMA) Has Changed Its Investment Story - Yahoo Finance
ADMA Biologics (NASDAQ:ADMA) Stock Price Down 8.7%Should You Sell? - MarketBeat
A Look At ADMA Biologics (ADMA) Valuation After Raised Guidance And New Long Term Growth Targets - Yahoo Finance
A Look At ADMA Biologics (ADMA) Valuation After New 2025–2027 Guidance And SG-001 Progress - Sahm
ADMA Biologics Highlights $510M+ 2025 Revenue, Raises 2027 Outlook at JPM Healthcare Conference - MarketBeat
Adma Biologics Inc (ADMA) 財務データ
収益
当期純利益
現金流量
EPS
Adma Biologics Inc (ADMA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Grossman Adam S | President and CEO |
Dec 15 '25 |
Sale |
19.79 |
21,000 |
415,590 |
2,007,850 |
| Grossman Adam S | President and CEO |
Nov 19 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,034,850 |
| Grossman Adam S | President and CEO |
Nov 19 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,013,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Option Exercise |
5.40 |
15,000 |
81,000 |
2,040,850 |
| Grossman Adam S | President and CEO |
Oct 24 '25 |
Sale |
16.00 |
21,000 |
336,000 |
2,019,850 |
1.24%
0.19%
大文字化:
|
ボリューム (24 時間):